Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

Journal of Neurosurgery

Volumn 85, Issue 4, 1996, Pages 602-607

  Kim, Lyndon ^a   Hochberg, Fred H ^a   Thornton, Allan F ^a   Harsh IV, Griffith R ^a   Patel, Heena ^a   Finkelstein, Dianne ^a   Louis, David N ^a  

^a NONE

Author keywords

anaplastic oligodendroglioma; marker of oligodendroglial cells; oligoastrocytoma; percentage of oligodendroglioma component; procarbazine lomustine vincristine chemotherapy

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; ASTROCYTOMA; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OLIGODENDROGLIOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; VOMITING;

EID: 0029841263     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.4.0602     Document Type: Article

References (24)

1. Bullard DE, Rawlings CE III, Phillips B, et al: Oligodendroglioma. An analysis of the value of radiation therapy. Cancer 60:2179-2188, 1987
2. Burger P, Scheithauer BW: Atlas of Tumor Pathology. Section 3. Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology, 1994
3. Burger PC. Scheithauer B, Vogel FS: Surgical Pathology of the Nervous System and its Coverings, ed 3. New York: Churchill Livingston, 1991, pp 306-324
4. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12:2013-2021, 1994
5. Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Progress report. Arch Neurol 48:225-227, 1991
6. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360-364, 1988
7. Duffau H, Albuquerque L, Ameri A, et al: Chemotherapy for newly diagnosed and recurrent anaplastic oligodendrogliomas and mixed gliomas: an analysis of 42 cases. Neurology 45 (Suppl 4):A261, 1995 (Abstract)
8. Dyer CA, Philibotte T: A clone of the MOCH-1 glial tumor in culture: multiple phenotypes expressed under different environmental conditions. J Neuropathol Exp Neurol 54:852-863, 1995
9. Glass J, Hochberg FH, Gruber ML, et al: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 76:741-745, 1992
10. Helpers MJHM, Budka H: Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol 64:265-272, 1984
11. Kleihues P, Burger PC, Scheithauer BW, et al: Histological Typing of Tumors of the Central Nervous System. Berlin: Springer-Verlag, 1993
12. Kraus JA, Koopmann J, Kaskel P, et al: Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95, 1995
13. Kyritsis AP, Yung WKA, Bruner J, et al: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-371, 1993
14. Lindegaard KF, Mørk SJ, Eide GE, et al: Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg 67:224-230, 1987
15. Louis DN, Gusella JF: A tiger behind many doors: multiple pathways to malignant glioma. Trends Genet 11:412-415, 1995.
16. Macdonald DR, Gaspar LE, Cairncross JG, et al: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27:573-574, 1990
17. Mørk SJ, Lindegaard KF, Halvorsen TB, et al: Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg 63:881-889, 1985
18. Nijjar TS, Simpson WJ, Gadalla T, et al: Oligodendroglioma. The Princess Margaret Hospital experience (1958-1984). Cancer 71:4002-4006, 1993
19. Sarkar C, Roy S, Tandon PN: Oligodendroglial tumors. An immunohistochemical and electron microscopic study. Cancer 61:1862-1866, 1988
20. Shaw EG, Scheithauer B, O'Fallon J, et al: Astrocytomas (A), oligo-astrocytomas (OA), and oligodendrogliomas (O): a comparative survival study. Neurology 42 (Suppl 4):342, 1992
21. Shaw EG, Scheithauer BW, O'Fallon JR, et al: Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 76: 428-434, 1992
22. Soffietti R, Chiò A, Mocellini C, et al: Response of oligodendroglial tumors to PCV chemotherapy. Neurology 44 (Suppl 4):A309, 1994 (Abstract)
23. Soffietti R, Chiò A, Mocellini C, et al: Treatment with carboplatinum of oligodendroglial tumors recurrent after PCV chemotherapy. Neurol 45 (Suppl 4):A261, 1995 (Abstract)
24. Stewart DJ, Dahrouge S, Soltys K, et al: A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults. J Neurooncol 23:249-252, 1995